Neutropenia as an Adverse Event following Vaccination: Results from Randomized Clinical Trials in Healthy Adults and Systematic Review

• Vincent Muturi-Kioi,

  Current address: GSK, Nairobi, Kenya

  Affiliation Novartis Vaccines Institute for Global Health, Siena, Italy

  ⨯
• David Lewis,

  Current address: Imperial College, London, United Kingdom

  Affiliation Surrey Clinical Research Centre, University of Surrey, Guildford, United Kingdom

  ⨯
• Odile Launay,

  Affiliation Université Paris Descartes, Sorbonne Paris cité, and Inserm CIC 1417, F-CRIN I-Reivac, Assistance Publique Hôpitaux de Paris, CIC Cochin-Pasteur, Paris, France

  ⨯
• Geert Leroux-Roels,

  Affiliation Ghent University and University Hospital, Gent, Belgium

  ⨯
• Alessandra Anemona,

  Current address: GSK Vaccines Institute for Global Health, Siena, Italy,

  Affiliation Novartis Vaccines Institute for Global Health, Siena, Italy

  ⨯
• Pierre Loulergue,

  Affiliation Université Paris Descartes, Sorbonne Paris cité, and Inserm CIC 1417, F-CRIN I-Reivac, Assistance Publique Hôpitaux de Paris, CIC Cochin-Pasteur, Paris, France

  ⨯
• Caroline L. Bodinham,

  Affiliation Surrey Clinical Research Centre, University of Surrey, Guildford, United Kingdom

  ⨯
• Annelies Aerssens,

  Affiliation Ghent University and University Hospital, Gent, Belgium

  ⨯
• Nicola Groth,

  Current address: GSK Vaccines, Siena, Italy

  Affiliation Novartis Vaccines & Diagnostics, Siena, Italy

  ⨯
• Allan Saul,

  Current address: GSK Vaccines Institute for Global Health, Siena, Italy,

  Affiliation Novartis Vaccines Institute for Global Health, Siena, Italy

  ⨯
• Audino Podda

  * E-mail: audino.p.podda@gsk.com

  Current address: GSK Vaccines Institute for Global Health, Siena, Italy,

  Affiliation Novartis Vaccines Institute for Global Health, Siena, Italy

  ⨯